1/41
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
Chief Cells
Secretory cells in the stomach that secrete pepsinogen, an inactive precursor of pepsin, which digests proteins.
Parietal Cells
Secretory cells in the stomach that secrete hydrochloric acid (HCl), which assists in digestion and provides an acidic environment for pepsin activity.
Mucus Cells
Secretory cells in the stomach that secrete mucus, which protects the stomach lining from acid and pepsin.
Gastroesophageal Reflux Disease (GERD)
Also known as heartburn; a common stomach disorder characterized by burning, bloating, belching, and regurgitation of gastric secretions into the esophagus.
Peptic Ulcer Disease (PUD)
Includes various stomach disorders, such as gastric and duodenal ulcers, characterized by burning, gnawing, and aching sensations in the stomach area.
Antacids
A drug class that buffers hydrochloric acid to decrease its concentration in the stomach, used to treat heartburn due to excessive eating/drinking and acute ulcers.
Histamine-2 Receptor Antagonists
A drug class that blocks H_2 receptors, resulting in decreased gastric acid secretion volume, used for GERD, duodenal ulcers, stress ulcers, and Zollinger-Ellison syndrome.
Misoprostol (Cytotec)
A gastrointestinal prostaglandin that inhibits gastric acid and pepsin secretion, used to prevent and treat gastric ulcers caused by NSAIDs, and is contraindicated in pregnancy.
Proton Pump Inhibitors
A drug class that inhibits gastric secretion by blocking the gastric acid pump of parietal cells, used to treat severe esophagitis, GERD, and gastric and duodenal ulcers.
Sucralfate (Carafate)
A coating agent that adheres to ulcer craters, protecting them from acids, pepsin, and bile salts, used for the treatment of duodenal ulcers, especially for patients intolerant of other therapies.
Metoclopramide (Reglan)
A prokinetic agent that reduces reflux, increases stomach contractions, relaxes the pyloric valve, and increases peristalsis, used for gastric reflux esophagitis, diabetic gastroparesis, and as an antiemetic.
Helicobacter pylori (H. pylori)
A bacterium whose infection may require antibiotic therapy in patients with GERD or PUD symptoms.
Extrapyramidal symptoms (EPS)
Serious adverse effects associated with prokinetic agents like metoclopramide, involving involuntary movements and other neurological symptoms.
Zollinger-Ellison syndrome
A condition characterized by excessive gastric acid secretion, which can be treated with Histamine-2 Receptor Antagonists.
Hypomagnesemia
A serious adverse effect associated with Proton Pump Inhibitor therapy.
Chief Cells
Secretory cells in the stomach that secrete pepsinogen, an inactive precursor of pepsin, which digests proteins.
Parietal Cells
Secretory cells in the stomach that secrete hydrochloric acid (HCl), which assists in digestion and provides an acidic environment for pepsin activity.
Mucus Cells
Secretory cells in the stomach that secrete mucus, which protects the stomach lining from acid and pepsin.
Gastroesophageal Reflux Disease (GERD)
Also known as heartburn, characterized by symptoms such as burning, bloating, belching, and regurgitation of gastric secretions into the esophagus.
Peptic Ulcer Disease (PUD)
Includes various stomach disorders, commonly gastric and duodenal ulcers, with symptoms like burning, gnawing, and aching sensations in the stomach area.
Antacids
A drug class that buffers hydrochloric acid to decrease its concentration in the stomach, used to treat heartburn.
Histamine-2 Receptor Antagonists
A drug class that blocks H2 receptors, resulting in decreased gastric acid secretion volume, used for GERD, duodenal ulcers, and Zollinger-Ellison syndrome.
Misoprostol (Cytotec)
A gastrointestinal prostaglandin that inhibits gastric acid and pepsin secretion, used to prevent and treat gastric ulcers caused by NSAIDs.
Proton Pump Inhibitors
A drug class that inhibits gastric secretion by blocking the gastric acid pump of parietal cells, used to treat severe esophagitis, GERD, and gastric/duodenal ulcers.
Sucralfate (Carafate)
A coating agent that adheres to ulcer craters, protecting them from acids, pepsin, and bile salts, primarily used for duodenal ulcers.
Metoclopramide (Reglan)
A prokinetic agent that reduces reflux, increases stomach contractions, relaxes the pyloric valve, and increases peristalsis, also used as an antiemetic.
Helicobacter pylori
A bacterial infection often treated with antibiotics, indicated for symptomatic Helicobacter pylori infection in the context of PUD.